Depilatories in Serbia

All of the three categories in depilatories hair removers/bleaches, womens pre-shave and womens razors and blades posted relatively strong current value growth during 2017. The main factors in this performance are the somewhat improved general economic conditions in the country, with disposable income growth being the most important. Many consumers who stopped purchasing some of these products during the economic crisis, as they saw them unnecessary, started doing so again.

Euromonitor Internationals Depilatories in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. Forecasts to 2022 illustrate how the market is set to change.

Product coverage: Hair Removers/Bleaches, Womens Pre-Shave, Womens Razors and Blades.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Depilatories market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


DEPILATORIES IN SERBIA
Euromonitor International
May 2018

LIST OF CONTENTS AND TABLES

Headlines
Prospects
All Categories Within Depilatories Perform Well in 2017
Improved Distribution and Changing Habits Lead To Particularly Strong Sales Growth for Hair Removers/bleaches
Drugstores/parapharmacies Remains the Leading Channel
Competitive Landscape
Private Label Lines Improve Their Position
Biokozmetika Doo and Lilly Drogerie Record the Highest Value Sales Growth
Depilatories Is Becoming More Concentrated
Category Data
Table 1 Sales of Depilatories by Category: Value 2012-2017
Table 2 Sales of Depilatories by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Depilatories: % Value 2013-2017
Table 4 LBN Brand Shares of Depilatories: % Value 2014-2017
Table 5 Forecast Sales of Depilatories by Category: Value 2017-2022
Table 6 Forecast Sales of Depilatories by Category: % Value Growth 2017-2022
Executive Summary
Beauty and Personal Care in Serbia Records Healthy Growth in 2017
Private Label Lines Become More Significant in Colour Cosmetics
the Leading Three Manufacturers Record Value Share Increases in 2017
New Formulas and Brand Extensions Mark New Product Launches in 2017
Stronger Growth Is Expected Over the Forecast Period
Market Data
Table 7 Sales of Beauty and Personal Care by Category: Value 2012-2017
Table 8 Sales of Beauty and Personal Care by Category: % Value Growth 2012-2017
Table 9 GBO Company Shares of Beauty and Personal Care: % Value 2013-2017
Table 10 NBO Company Shares of Beauty and Personal Care: % Value 2013-2017
Table 11 LBN Brand Shares of Beauty and Personal Care: % Value 2014-2017
Table 12 Penetration of Private Label in Beauty and Personal Care by Category: % Value 2012-2017
Table 13 Distribution of Beauty and Personal Care by Format: % Value 2012-2017
Table 14 Distribution of Beauty and Personal Care by Format and Category: % Value 2017
Table 15 Forecast Sales of Beauty and Personal Care by Category: Value 2017-2022
Table 16 Forecast Sales of Beauty and Personal Care by Category: % Value Growth 2017-2022
Sources
Summary 1 Research Sources













Type 2 Diabetes - Pipeline Review, H2 2019

Type 2 Diabetes - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Pipeline Review, H2 2019, provides an overview of the Type 2 Diabetes

USD 2500 View Report

Age Related Macular Degeneration - Pipeline Review, H2 2019

Age Related Macular Degeneration - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration - Pipeline Review, H2 2019, provides an overview of the Age

USD 2500 View Report

Type 2 Diabetes - Pipeline Review, H2 2019

Type 2 Diabetes - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Pipeline Review, H2 2019, provides an overview of the Type 2 Diabetes

USD 2500 View Report

Age Related Macular Degeneration - Pipeline Review, H2 2019

Age Related Macular Degeneration - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration - Pipeline Review, H2 2019, provides an overview of the Age

USD 2500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available